AstraZeneca (AZN) PT Raised to $220 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Andrew Berens raised the price target on AstraZeneca (NASDAQ: AZN) to $220.00 (from $219.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
